Evidence map›Paper›PMID 31970526›Full record

ArticleMikrochimica acta2020

CdSe quantum dots capped with a deep eutectic solvent as a fluorescent probe for copper(II) determination in various drinks.

Susan Sadeghi, Abdolbaset Davami

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Susan SadeghiDepartment of Chemistry, Faculty of Science, University of Birjand, Birjand, Iran. ssadeghi@birjand.ac.ir.
Abdolbaset DavamiDepartment of Chemistry, Faculty of Science, University of Birjand, Birjand, Iran.
University of Birjand · IR

Funding

University of Birjand 2016-35703
6 · The paper itself

Abstract

The present study shows that copper(II) ions can be determined with a new fluorescent probe that is based on the use of CdSe quantum dots capped with deep eutectic solvent (DES-CdSe QDs). The capped QDs were prepared in aqueous phase by a one-step procedure under ambient atmosphere using selenium dioxide as a stable precursor for selenium, and ascorbic acid as non-toxic reducing agent. The deep eutectic solvent is composed of choline chloride and thioglycolic acid and acts as stabilizing and functionalizing agent. The fluorescent probe undergoes an increase in the fluorescence intensity (with excitation/emission wavelengths at 380/560 nm) in the presence of Cu(II). Other ions display no significant effect on fluorescence. The effects of sample pH value, concentration of buffer, and volume of QDs solution were optimized by response surface methodology using a Box-Behnken statistical design. Under the optimal conditions, the response of the probe is linear in the 10-600 nM Cu(II) concentration range, with a 5.3 nM limit of detection. This is lower than the allowable maximum Cu(II) concentration in drinking water. The relative standard deviation of the method for five replicate measurements of Cu(II) at a 100 nM concentration level is 2.0%. The probe was successfully applied to the determination of Cu(II) in various drinks. Graphical abstractSchematic representation of a fluorometric method for the determination of Cu(II) at nanomolar concentration levels. The fluorescent system consists of deep eutectic solvent-capped cadmium selenide quantum dots (DES-CdSe QDs). Fluorescence is strongly enhanced by copper(II).

Indexed as

Box Behnken designCapped QDsCu(II) determinationDeep eutectic solventDrink analysisFluorescent probe

Identifiers

PMID31970526
OpenAlexW3001159819

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.